126 related articles for article (PubMed ID: 29210715)
1. Blistering and Skin Fragility Due to Imatinib Therapy: Loss of Laminin and Collagen IV as a Possible Cause of Cutaneous Basement Membrane Instability.
Mühl S; Ehrchen J; Metze D
Am J Dermatopathol; 2018 May; 40(5):371-374. PubMed ID: 29210715
[TBL] [Abstract][Full Text] [Related]
2. Changes in connective tissue macromolecular components of Yucatan mini-pig skin following application of sulphur mustard vapour.
Lindsay CD; Rice P
Hum Exp Toxicol; 1995 Apr; 14(4):341-8. PubMed ID: 7598994
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical localization of basement membrane laminin 5 and collagen IV in adult linear IgA disease.
El-Domyati M; Abdel-Wahab H; Ahmad H
Int J Dermatol; 2015 Aug; 54(8):922-8. PubMed ID: 25771892
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of Brunsting-Perry type pemphigoid: a case showing blister formation at the lamina lucida, immune deposition beneath the lamina densa and autoantibodies against the 290-kD polypeptide along the lamina densa.
Minato H; Ishii N; Fukuda S; Wakasa T; Wakasa K; Sogame R; Hashimoto T; Horiguchi Y
J Dermatol; 2011 Sep; 38(9):887-92. PubMed ID: 21366683
[TBL] [Abstract][Full Text] [Related]
5. Alterations of basement membrane zone in bullous and non-bullous variants of extragenital lichen sclerosus.
Kowalewski C; Kozlowska A; Zawadzka M; Woźniak K; Blaszczyk M; Jablońska S
Am J Dermatopathol; 2004 Apr; 26(2):96-101. PubMed ID: 15024189
[TBL] [Abstract][Full Text] [Related]
6. Laminin in the cutaneous basement membrane as a potential target in lewisite vesication.
King JR; Peters BP; Monteiro-Riviere NA
Toxicol Appl Pharmacol; 1994 May; 126(1):164-73. PubMed ID: 8184425
[TBL] [Abstract][Full Text] [Related]
7. Basal lamina components in experimentally induced skin blisters.
Saksela O; Alitalo K; Kiistala U; Vaheri A
J Invest Dermatol; 1981 Sep; 77(3):283-6. PubMed ID: 7021698
[TBL] [Abstract][Full Text] [Related]
8. Histopathology of anti-laminin 5 mucous membrane pemphigoid.
Rose C; Schmidt E; Kerstan A; Thoma-Uszynski S; Wesselmann U; Käsbohrer U; Zillikens D; Shimanovich I
J Am Acad Dermatol; 2009 Sep; 61(3):433-40. PubMed ID: 19700013
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
[TBL] [Abstract][Full Text] [Related]
10. Basement membrane components and galactosylhydroxylysyl glucosyltransferase in suction blisters of human skin.
Oikarinen A; Savolainen ER; Tryggvason K; Foidart JM; Kiistala U
Br J Dermatol; 1982 Mar; 106(3):257-66. PubMed ID: 6279137
[TBL] [Abstract][Full Text] [Related]
11. Intraepidermal expression of basement membrane components in the lesional skin of a patient with dystrophic epidermolysis bullosa.
Muramatsu T; Ko T; Honoki K; Hatoko M; Shirai T; Vnittanakom P
J Dermatol; 1999 Feb; 26(2):106-10. PubMed ID: 10091480
[TBL] [Abstract][Full Text] [Related]
12. A case of subepidermal blistering disease with autoantibodies to multiple laminin subunits who developed later autoantibodies to alpha-5 chain of type IV collagen associated with membranous glomerulonephropathy.
Sueki H; Sato Y; Ohtoshi S; Nakada T; Yoshimura A; Tateishi C; Borza DB; Fader W; Ghohestani RF; Hirako Y; Koga H; Ishii N; Tsuchisaka A; Qian H; Li X; Hashimoto T
Acta Derm Venereol; 2015 Sep; 95(7):826-9. PubMed ID: 25633161
[TBL] [Abstract][Full Text] [Related]
13. Imatinib-induced agranulocytosis in patients with gastrointestinal stromal tumors.
Farag S; Verschoor AJ; Bosma JW; Gelderblom H; Kerst JM; Sleijfer S; Steeghs N
J Clin Pharmacol; 2015 Aug; 55(8):920-5. PubMed ID: 25810235
[TBL] [Abstract][Full Text] [Related]
14. Pemphigus foliaceus in a patient with gastrointestinal stromal tumor treated with adjuvant imatinib mesylate.
Lewis HA; Chen DY; Rosman IS; Picus J; Anadkat MJ
Dermatol Online J; 2020 Jun; 26(6):. PubMed ID: 32815695
[TBL] [Abstract][Full Text] [Related]
15. Skin fragility and blistering with imatinib mesylate.
Verma SM; Murphy G
J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):496-8. PubMed ID: 19925597
[No Abstract] [Full Text] [Related]
16. Imatinib-induced Gastrointestinal Vascular Ectasia in a Patient with Advanced GIST: Case Report and Literature Review.
Abu-Amna M; Awadie H; Bar-Sela G
Anticancer Res; 2016 Nov; 36(11):6151-6154. PubMed ID: 27793944
[TBL] [Abstract][Full Text] [Related]
17. A safety evaluation of imatinib mesylate in the treatment of gastrointestinal stromal tumor.
Ben Ami E; Demetri GD
Expert Opin Drug Saf; 2016; 15(4):571-8. PubMed ID: 26865352
[TBL] [Abstract][Full Text] [Related]
18. Hyperpigmentation due to imatinib: A rare case of cutaneous involvement.
Rehman H; Hakim N; Sugarman R; Seetharamu N; Saif MW
J Oncol Pharm Pract; 2020 Sep; 26(6):1511-1515. PubMed ID: 32067560
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin G deposition to nonhemidesmosomal lamina lucida and early neutrophil involvement are characteristic features in a case of anti-p200 pemphigoid.
Shimizu A; Funakoshi T; Ishibashi M; Yoshida T; Koga H; Hashimoto T; Amagai M; Ishiko A
Br J Dermatol; 2013 Mar; 168(3):647-55. PubMed ID: 22963596
[TBL] [Abstract][Full Text] [Related]
20. Alterations of basement membrane zone in autoimmune subepidermal bullous diseases.
Woźniak K; Kowalewski C
J Dermatol Sci; 2005 Dec; 40(3):169-75. PubMed ID: 15990279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
